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NADH:ubiquinone oxidoreductase (Complex I, CI) is one of the
major sources of reactive oxygen species (ROS) in mitochondria. ROS
are critically involved in several degenerative diseases like Leigh
syndrome, Leber's hereditary optic neuropathy or Parkinson's disease.
CI-dependent ROS formation occurs at the NADH-site and is driven by
the fully reduced ﬂavin mononucleotide (FMN) rather than the
semireduced FMN radical. The importance of several conserved
amino acids in vicinity to FMN has been shown by structural analysis.
Glu95, Glu97 and Tyr180 in NuoF from Aquifex aeolicus (human
orthologue NDUFV1) are suggested to be involved in electron transfer
from NADH to FMN. Furthermore, Tyr180 is of pathophysiological
relevance indicated by a mutation in a CI-deﬁcient patient (human
orthologue Tyr204).
To investigate the contribution of these amino acids on ROS
formation we used a surrogate model of CI. We coexpressed NuoE and
NuoF from A. aeolicus in Escherichia coli, which results in soluble
NuoEF protein, containing FMN and the Fe–S-clusters N3 and N1a.
Site-directed mutagenesis in NuoF at the positions Glu95, Glu97 and
Tyr180 was used to generate mutant NuoEF. The (mutant) proteins
were investigated by steady state kinetics and redoxtitrations, to
assess the impact of the respective amino acids on ROS formation.
Wild type NuoEF protein generates ROS in a FMNH2-dependent
manner at rates of 110 nmol/min*mg. FMN potential (E0) is−0.320 V
(at pH 7.5) which is comparable to data obtained from CI in E. coli.
Mutations in NuoF critically affect ROS production, e.g. Y180A showed
4-fold higher ROS production, contrasted by Y180L where ROS
production was reduced to 40%. Interestingly, these mutant proteins
show a different behavior in redoxtitrations pointing to a mechanistic
change of ROS production by CI.
These ﬁndings indicate that small changes in the structural
environment of the FMN substantially affect the potential or stability
of different FMN species which affect ROS formation and might have
implications for diseases associated with CI-dysfunction.
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Mitochondrial NADH:ubiquinone oxidoreductase (complex I) is an
L-shaped membrane protein that has a central function in oxidative
phosphorylation. The overall architecture of complex I was determined
using X-ray crystallography, however the mechanism of redox-driven
proton-pumping remains to be elucidated. Electrons are transferred
fromNADH via a chain of Fe–S clusters to reduce ubiquinone bound in a
deep binding pocket that is comprised of the 49-kDa and PSST subunits
of complex I. Iron–sulfur cluster N2, the immediate electron donor for
ubiquinone, resides about 30 Å above the membrane domain. The
binding of the ubiquinone head group is mainly stabilized by
hydrogen bond interactions to the conserved Y144 of subunit 49-
kDa. To investigate the pathway of the hydrophobic tail, ﬁve
chemically modiﬁed ubiquinone derivatives were applied as sub-
strates in enzyme kinetics measured with mitochondrial membranes
of complex I mutants. We concluded from these extended structure/
function analyses that the tail of ubiquinone enters through a narrow
hydrophobic path at the interface between the 49-kDa and PSST
subunits. Furthermore, we identiﬁed several conserved methionines
that seem to form a structural and functional hydrophobic gate to the
active site reminiscent to the M-domains of the signal recognition
particle of the endoplasmic reticulum. To gain further insight into the
architecture of the ubiquinone binding domain, ﬁve amino acids
within the binding pocket of the 49-kDa subunit of Yarrowia lipolytica
were changed by site-directed mutagenesis to match the amino acid
pattern of bovine complex I in this region. We could show that
residue S192 is responsible for the decreased sensitivity of yeast
complex I towards the inhibitor rotenone.
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Complex I or NADH:ubiquinone oxidreductase is the ﬁrst and
largest enzyme of the respiratory chain. Mammalian mitochondrial
complex I is composed of at least 45 subunits with a molecular weight
of 980 kDa. Despite recent progress in structural studies, many
aspects of the regulation of the enzyme are still not clearly
understood. Mammalian enzyme can exist in catalytically active (A)
form and de-active, dormant (D) form. When the turnover of the
enzyme is limited the A-form undergoes reversible de-activation at
physiological temperatures. Until now, the exposure of Cys 39 of the
ND3 subunit after de-activation is the only conformational difference
observed between the A and the D-form, accounting for the
sensitivity of the D-form to SH-reagents [1].
Using two homogenous preparations of bovine heart submito-
chondrial particles containing either the A or the D-form of complex I,
we observed no difference in the proﬁle of respiratory chain enzymes
shown by Blue Native PAGE [2]. Moreover, Cys 39 is accessible for SH-
reagents in the D-form of the enzyme even when complex I is a part
of respiratory chain supercomplexes. To characterise the relative
location of Cys 39 of the ND3 subunit we used internal protease
bromoacetamidobenzyl-EDTA (Fe-BABE)-SH-reagent for differential
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